Other Solid Tumors Active Not Recruiting Phase 1 Trials for Spartalizumab (DB14892)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02607813Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway AlterationsTreatment